Comgest Growth Europe USD AccRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 30-04-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | - | - | -20,6 | 23,0 | 5,6 | |
+/-Cat | - | - | -0,1 | 6,9 | 0,2 | |
+/-Idx | - | - | - | 6,8 | -1,8 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Categorie Benchmark: Morningstar DM Europe Grt T... |
Kerngegevens | ||
Koers 02-05-2024 | USD 9,96 | |
Rendement 1 Dag | -0,74% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
Vestigingsland | Ierland | |
ISIN | IE00BMBWVL69 | |
Grootte Fonds (Mil) 02-05-2024 | EUR 6193,59 | |
Grootte Fondsklasse (Mil) 02-05-2024 | USD 2,63 | |
Aankoopkosten (Max) | 4,00% | |
Lopende Kosten Factor 21-03-2024 | 1,56% |
Morningstar Research |
Analyst Report | 20-09-2023 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Klik hier voor het analistenrapport |
Pijlers Morningstar | |
---|---|
Team | 25 |
Fondshuis | 24 |
Proces | 25 |
Rendement | |
Kosten |
Beleggingsdoelstelling: Comgest Growth Europe USD Acc |
The investment objective of the Comgest Growth Europe fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies based or operating in Europe. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Franz Weis 01-11-2009 | ||
Pierre Lamelin 28-02-2022 | ||
Click here to see others | ||
Oprichtingsdatum 13-12-2021 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Comgest Growth Europe USD Acc | 31-01-2024 |
|
|
Top 5 posities | Sector | % |
ASML Holding NV | Technologie | 8,88 |
Novo Nordisk A/S Class B | Gezondheidszorg | 8,48 |
Accenture PLC Class A | Technologie | 4,80 |
Essilorluxottica | Gezondheidszorg | 4,60 |
Experian PLC | Industrie | 4,18 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Comgest Growth Europe USD Acc |